Mangoceuticals (MGRX) stock price, chart and financials

Price chart

Revenue (trailing twelve months)

$315,227.00

Revenue (quarter)

$68,757.00

Revenue growth (year over year)

−59.10%

Gross profit (trailing twelve months)

$171,590.00

Gross margin

54.43%

Net income (trailing twelve months)

−$15.1M

Net income (quarter)

−$1.3M

Net income growth (year over year)

+75.76%

Net margin

−4791.54%

Return on equity

−102.49%

EPS (trailing twelve months)

−$1.00

Book value per share

$0.70

P/E (trailing twelve months)

—

Price to book

0.61

Debt to assets

11.63%

Payout ratio

—

Dividend yield

—

Company profile

Mangoceuticals Inc focuses on developing, marketing, and selling a variety of men's wellness products and services through a telemedicine platform. The company's platform provides access for customers to a licensed pharmacy for online fulfillment and distribution of certain medications that may be prescribed as part of telehealth consultations, including Mango ED products.

• Is Mangoceuticals (MGRX) profitable?

  No. Mangoceuticals reported a net loss of $15.1M over the trailing twelve months.

• How much revenue does Mangoceuticals (MGRX) make?

  Mangoceuticals generated $315,227.00 in revenue over the trailing twelve months, down 59.10% year over year.

• How do I buy stock in Mangoceuticals (MGRX)?

  MGRX trades commission-free with a Light Horse Securities brokerage account — from the mobile app, the web at Light Horse Dashboard, the trading API, or an AI agent connected over MCP. The trade panel on this page places the order once you are signed in.